Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-89
SponsorGeisinger Clinic

About this trial

The goal of this clinical trial is to learn if receiving peer recovery support (support services provided by trained "peers" with lived experience of addiction and recovery) improves retention in medication treatment among people with opioid use disorder. The main question it aims to answer is: does peer recovery support improve retention in medication treatment for opioid use disorder?

Researchers will compare two groups: (1) standard care combined with a peer recovery support program, and (2) standard care alone, to see if peer recovery support works to improve retention in medication treatment for opioid use disorder.

Participants will: visit clinics as they normally would to receive standard care (medication treatment for opioid use disorder); complete two questionnaires - one when they start treatment and one 6 months later; and agree to let researchers use information from their medical record. Participants in group 1 will also be invited to meet with a peer recovery support specialist for up to 6 months.

Eligibility criteria

Qualifiers

Adult ≥ 18 years of age

Initiated medication for opioid use disorder treatment in past 45 days in a Geisinger outpatient clinic

Willing and able to give informed consent

Disqualifiers

Received medication for opioid use disorder treatment at a Geisinger outpatient clinic in the 90-day period prior to the treatment initiation date

Not proficient in English

Trial design

Treatments tested in this trial

  • Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment

Treatment groups

218 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Geisinger Clinic

Lead sponsor

UConn Health

Collaborator